The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma

Treatment with direct-acting anitiviral agents has revolutionized the treatment of chronic HCV infection. In the near future, these novel therapies will have a profound impact on HCV prevalence and HCV-induced carcinogenesis. In this review, we discuss treatment options of HCV patients with both compensated and decompensated cirrhosis as well as HCV patients in pre- and post-transplantation settings with a focus on the currently available data on HCC development in these patient populations

from Cancer via ola Kala on Inoreader http://ift.tt/1NN4Dtt
via IFTTT